Medtech sounds alarm on semiconductor shortages, asks feds to prioritize chips for medical use

📊Executive Summary
The article highlights the significant impact of semiconductor shortages on the medical technology sector, with companies like Philips and BD reporting lead times extending from weeks to over a year. Philips has seen its semiconductor inventory drop to zero, while BD is placing orders 18-24 months in advance to ensure supply continuity. The situation is exacerbated by rising costs, with BD noting price markups of 36-100 times compared to the previous year. The medical industry is urging the government to prioritize semiconductor allocation for medical use and increase fabrication capacity domestically and with allied partners. This situation poses a critical challenge for procurement teams in medtech, requiring immediate attention to sourcing strategies....
More Insights Available
Unlock Full Analysis
Sign in to access the complete executive brief, risk analysis, and full article content.
